While the origin of the phrase "birds of a feather flock together" is unclear, it has been in use for centuries and is typically employed to describe the phenomenon that people with similar tastes or interests tend to seek each other out and congregate together.
| INTRODUCTION
This review will focus on MC and eosinophil similarities during differentiation and maturation and their response to external stimuli.
While they do have a comparable repertoire of surface receptors (see Table 1 ), their responses and reactions often vary. Replete with granules, both MCs and eosinophils harbor a unique collection of prestored mediators to be released upon their activation. They also have overlapping but distinct patterns of newly formed lipid and protein mediators.
Thus, key similarities and differences will be highlighted while summarizing what is known about their paired roles in allergies and other relevant disorders. 
| ORIGIN AND DEVELOPMENT

| Hematopoietic lineage
I N V I T E D R E V I E W
Human eosinophils and mast cells: Birds of a feather flock together
from common myeloid progenitors. 1 However, the origin of human MC-committed progenitors is still controversial. Studies in mice suggest they come from granulocyte/monocyte progenitors downstream of common myeloid progenitors. 2 To make matters more complicated, distinct developmental pathways and tissue microenvironments govern MC phenotypes, ie, tryptase-positive (MC T ) and tryptase/ chymase-positive (MC TC ). 3 
| Differentiation and maturation
Differentiation of progenitors, toward a terminal MC or eosinophil fate, is a complex process regulated by transcription factors and extrinsic signals such as cytokines. The most pertinent transcription factors in eosinophil differentiation are GATA-1 and C/EBPα, because their forced expression in human myeloid progenitors results in eosinophil formation. 4, 5 In addition, PU.1 and FOG-1 indirectly contribute to the emergence of eosinophils because augmentation of either one shifts progenitors towards an alternate fate. [6] [7] [8] [9] Recent studies in mice have identified additional transcription factors important for eosinophil differentiation; Helios and Aelios, which regulate gene expression during development, 10 and X-box binding protein 1, critical for eosinophil differentiation and granulogenesis. 11 Another protein necessary for eosinophil granularity and survival in mice is cystatin F. 12 In MCs,
GATA-1 and GATA-2 drive differentiation and regulate transcription of FcεRI and KIT genes. 3 PU.1 also promotes MC development, but expression becomes weaker as MCs mature. 9 Similar to eosinophils, FOG-1 inhibits MC differentiation, redirecting progenitors toward other cell lineages. 9, 13 MCs and eosinophils both originate in the bone marrow, but eosinophils enter the circulation as mature cells while MCs circulate as progenitors and become mature once they reach the tissues where they ultimately reside (as reviewed in 13, 14) . Growth factors are important for regulating a variety of cellular processes including differentiation and proliferation. Eosinophil maturation and proliferation is dependent on cytokines IL-3, IL-5 and granulocyte macrophage colony-stimulating factor (GM-CSF), for which receptors are expressed on eosinophil precursors and feature a common β chain. While different combinations of these cytokines generally can promote eosinophilic differentiation and proliferation, the three together greatly enhance both. 15 It is well established that IL-5 is selective for eosinophil production and also mediates their release from the bone marrow. 16 The importance of IL-5 to eosinophil development has been further demonstrated in recent trials of now approved anti-IL-5 and anti-IL-5 receptor monoclonal antibodies that attenuated eosinophil numbers. 17 Of note, it was recently reported in mice that IL-33 can expand eosinophil progenitors upstream of IL-5 and promote upregulation of IL-5Rα. 18 IL-5R is a critical component of eosinophil lineage commitment and is responsible for the occurrence of increased eosinophil numbers observed in allergic inflammation (eg, increased blood and sputum eosinophils in asthmatic patients following allergen challenge). 19 Interestingly, IL-4Rα supports IL-5 mediated maturation of eosinophils when IL-5 is present, but in the absence of IL-5, CCL3 (from eosinophil precursors)
can promote cell differentiation through CCR1. 20 In homeostatic conditions, eosinophils are found at low numbers in the circulation, and primarily home to tissues where eotaxin-1 (CCL11) is constitu- and KIT inhibits activation in cord blood-derived MCs and in human MC leukaemia-1 (HMC-1) cells. 70 The inhibitory effects of CD300a was also highlighted in CD300a null mice, where IgE activation of MCs triggered an increased release of cytokines and chemokines compared to MCs in wild type control mice. 71 In human peripheral blood eosinophils, activation of CD300a inhibits chemotactic responses to eotaxin-1, and IL-5 and GM-CSF-associated survival and cytokine release.
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CD300c is also expressed on human MCs. 73 It is characterized by the presence of a cytoplasmic ITAM-bearing FcRγ chain 74 and its ligation results in MC activation. 73 Lastly, MCs and eosinophils both express inhibitory CD300f. 75 Increased expression of CD300f has been detected on eosinophils from allergic rhinitis patients. 76 The primary ligands for
CD300f are sphingolipids, such as sphingomyelin and ceramide. 77, 78 Activated CD300f can inhibit FcεRI-driven MC activation. 77 Of note, CD300f can also display an activating phenotype when cross-linked with mutated ITIM-expressing receptors.
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Leukocyte immunoglobulin-like receptors (LILRs) are another group of cell surface proteins with both activating and inhibitory properties. Human eosinophils express activating LILRA2 and inhibitory LILRB1, B2 and B3 on their surface. 79 MC precursors express LILRB1, B2, B3, B4 and A1, 80 while mature MCs express LILRB5 on their granules. In MCs, it is suggested that LILRs play a role in downregulating inflammatory responses. 80 However, studies suggest they promote activation in eosinophils. 79 To date, therapeutics targeting LILRs have yet to be developed, but theoretically targeting of these receptors might be useful in treating cancer and autoimmune diseases. that MCs numbers were reduced in pediatric EoE patients undergoing mepolizumab therapy, an effect not observed in mepolizumabtreated adult patients. 92 The most common IL-13 receptor contains α chain 1 and has weak binding capacity that is strengthened upon formation of a heterodimer complex with IL-4Rα. 93 Human eosinophils express low levels of IL-13Rα1, which can be upregulated by TGFβ or IFNγ. 94 Human lung MCs and the immature MC line HMC IgE activates sphingosine kinases that produce S1P, whose pleiotropic properties can be attributed to the fact that S1P binds to five different GPCRs. 158 MCs express S1PR1 and when activated it promotes MC movement. S1PR2 activation halts MC movement and initiates degranulation and release of pro-inflammatory mediators. 159, 160 The MC/S1P/S1PR2 axis was recently shown to be crucial for propagating early inflammatory responses in murine models of pulmonary and cutaneous allergic responses. 154, 155 Additionally, S1PR2 ligation leads to production of tissue remodeling matrix metalloproteinase-2 (MMP2) and vascular endothelial growth factor (VEGF)-α from human MCs. 161 Eosinophils express S1PR1, 3, 4, and 5 and can therefore be recruited to inflamed tissues by MCs and other S1P-producing cells. Eosinophil chemotaxis toward S1P can be abrogated in the presence of the pharmacological S1P receptor antagonist FTY-720, which has significant affinity for all S1PR except S1PR2. 162 Histamine is another MC-produced mediator that stimulates eosinophil recruitment through histamine GPCRs. 163 For eosinophils, histamine can act as a chemoattractant through H1R 164 and inhibit chemotaxis through H2R (when histamine concentration is high). on eosinophils from the skin of AD patients is upregulated as well. 184 Activation of 2B4 on eosinophils contributes to cell adhesion and migration 185 and induces degranulation. 72 In vivo activation of human eosinophils by the S. aureus endotoxin B (SEB) leads to the formation of sCD48 and upregulates transcription of CD48. 184, 186 Interactions between CD48 on MCs and 2B4 on eosinophils are an important part of the physical formation of the AEU and its pro-inflammatory prop- 198 can be produced by MCs, and it has been reported that MC progenitors express IL-5R, 90 suggesting that this mediator could be involved in the mutual regulation of these two cells.
| Cytokine receptors
contributes to the perivascular localization of MCs. 131-133 Another α4 integrin expressed by eosinophils and MCs is α4β7, which binds mu
| Toll-like receptors and others
| Eicosanoids
Prostaglandins are arachidonic acid derivatives produced by the activity of phospholipase A2 and cyclooxygenase enzymes (COX 1 and 2) from membrane phospholipids. MCs and eosinophils have both COX On eosinophils, DP1 and CRTH2 have some overlapping and cooperative functions, since both receptors are able to induce the egress of eosinophils from bone marrow, and mediate chemotactic activity and production of leukotriene C4 (LTC4). 204 In asthma models, PGD 2 activation of eosinophils increases their degranulation, mobilization and recruitment in the lungs through CRTH2. Currently, a CRTH2 antagonist, fevipiprant, is being tested in asthma clinical trials. 205, 206 Leukotrienes (LTs) are also rapidly synthesized and released following MC and eosinophil activation. 207 The main leukotrienes produced by MCs and eosinophils are products of lipoxygenase 5 activity on arachidonic acid and they comprise the cysteinyl leukot- 218 and death induced by Siglec-8 activation in cytokine-primed eosinophils is completely dependent on internal ROS generation. 66 The opposite effects of ROS production by MCs and eosinophils are interesting and raise questions about the possible effect of treatment with ROS scavengers.
| Histamine
MCs, together with basophils, are the only eukaryotic cell sources of preformed histamine that they release promptly upon activation. 223 Histamine is involved not only in allergy and anaphylaxis, but it is also important for immunomodulation, cell proliferation, wound healing, neurotransmission, stimulation of gastric secretion, regulation of blood pressure, perception of pain etc. 224 There are four receptors for histamine, H1-4R, some of which are expressed on MCs and eosinophils (discussed above and in another review of this series).
| MAST CELLS AND EOSINOPHILS IN ALLERGIC DISEASE
| Atopic dermatitis
AD is a chronic eczematous disease characterized by itchy, dry, and inflamed skin, which affects 10-20% of the world's population including both adults and children. 225 MC and eosinophil activation is a common characteristic of this disease. AD is often the first manifestation of allergies and is considered the first step in the atopic march because affected individuals are likely to develop food allergies, asthma and rhinitis. 226 Mutations in FLG, the gene encoding filaggrin, are the most well known risk factors for genetic predisposition of AD. Filaggrin is a protein involved in maintenance of the epidermal architecture and keratinocyte development. Thus, mutations in this gene can disrupt the structure of the skin barrier, resulting in increased permeability to allergens. 226 Interestingly, skin barrier impairment correlates with infections from S. aureus, 227 a main player in AD, that produces toxins such as enterotoxins which can act like superantigens. 224, 228, 229 Activated
MCs and eosinophils are found in AD lesions and both can be activated by S. aureus directly via TLRs or CD48. 182, 184 MCs are in part responsible for the itching and skin dryness experienced by AD patients due to their release of histamine, tryptase and other pro-inflammatory mediators. 230 Moreover, MCs produce IL-4 and IL-13, which promote eosinophil recruitment, via stimulation of chemokine production from keratinocytes and fibroblasts. Eosinophils recruited to AD lesional skin by MCs, once activated, discharge several mediators that contribute to AD symptoms. For example, eosinophil cationic protein (ECP), EDN and MBP have the ability to increase permeability of blood vessels and neurotoxic properties, while chemokines such as CCL11 can increase eosinophil recruitment. 226 Moreover, MC-derived substances contribute to the recruitment of other immune cells such as lymphocytes, macrophages, and eosinophils. 190 The release of mediators such as histamine, PGD 2 , LTC 4 , cytokines and others by MCs contribute to bronchoconstriction, mucus secretion, and mucosal edema. 232 The role of eosinophils in asthma, via release of granule proteins and other substances, is probably multifactorial (reviewed by 198). Based on clinical trials employing eosinophil targeting agents anti-IL-5 and anti-IL-5R, the most consistent finding is that of ≈50% reduction in asthma exacerbations, with little to no effect on lung function or airways hyperreactivity. 233 The notable role of MCs and eosinophils in asthma makes them useful as biomarkers for diagnosis and treatment. For example different eosinophil and MC products, including CharcotLeyden crystal protein and carboxypeptidase A3, respectively, have the potential to predict patient responses to oral corticosteroid treatment. 234 Patients who successfully respond to treatment have high levels of these proteins initially, which decrease following treatment. 234 Another possible marker for asthma is CD48 expressed by MCs and eosinophils. Moderate asthma patients exhibit increased CD48 compared to healthy controls, while CD48 levels in patients with severe asthma are decreased compared to moderate asthma patients. In contrast, sCD48 levels were higher in patients with mild asthma compared to control and decreased levels were detected in moderate patients compared to mild and even lower levels in patients with severe asthma. 183 More studies are needed to provide the ideal combination of biomarkers to direct asthma care.
| Asthma
| Rhinitis
Allergic rhinitis, or hay fever, manifests as inflammatory conditions that affect the nasal mucosa, usually accompanied by sneezing, itch- Histamine and tryptase levels in the blood can both increase during food-induced anaphylaxis, directly implicating MCs in food allergy. 247 Furthermore, platelet activating factor, which has been linked to disease severity, can also be produced and released by MCs. 247 MC activation through IgE had been linked to IL-9 and IL-33 production, both of which have been shown to play a role in disease pathogenesis.
Eosinophils are more predominantly featured within the inflamed GI tract of patients with non-IgE mediated food allergies (eg, eosinophilic esophagitis, EoE). 245 EoE features include abdominal pain, painful swallowing (dysphagia) and sometimes food impaction and is more common in males. 245 Inflammation is primarily eosinophilic and is defined by presence of at least 15 eosinophils/HPF in biopsy sections. 248 The EoE transcriptome has been described, with CCL26 (eotaxin-3), an eosinophil chemoattractant, and MC carboxypeptidase being among the most highly induced genes. 249 that MC numbers were attenuated within a group of pediatric EoE patients undergoing anti-IL-5 treatment. They also discovered that both eosinophils and MCs were producing IL-9 and that MC numbers correlated with disease severity. 91 
| Urticaria
Urticaria, or hives, occurs in 15%-25% of the population sometime during their lifetime and is characterized by pruritic lesions containing a pale center also known as a wheal with surrounding redness known as a flare. 253 Associated inflammation can be acute, but nearly 30% of urticaria patients experience chronic lesions defined by recurrent episodes for at least 6 weeks. 253 While urticaria can result from physical stimuli (ie, temperature or direct stroking of the skin), non-physical cases are sometimes categorized as autoimmune but most commonly are idiopathic. 254 MCs are considered a primary effector cell responsible for initiation of inflammation, in part due to release of histamine and cell-recruiting chemokines. While the exact contribution and trigger of MCs in urticaria remains controversial, 255, 256 it has been shown that histamine release correlates with an autoimmune phenotype. 254 Recent guidelines agree that anti-histamines are the mainstay of initial treatment for chronic urticaria, even though responses can vary. 257 Omalizumab, an anti-IgE monoclonal antibody, is another approved treatment option that is effective in over 60% of anti-histaminerefractory patients. 258 Eosinophils also participate in chronic urticaria, primarily in patients lacking an autoimmune component, and accumulate in urticarial lesions where MBP and ECP can also be detected. 259 Marques et al 260 recently conducted a study where they found that tissue eosinophilia was linked to disease severity in patients with chronic urticaria.
| MAST CELLS AND EOSINOPHILS DURING BACTERIAL, VIRAL, AND PARASITIC INFECTIONS
Beyond their involvement in allergic inflammation, MCs and eosinophils also serve a protective role during infection and host defense against viruses, bacteria, and parasites. MCs and eosinophils are uniquely placed at the interface between the outer environment and tissues, allowing for their response to penetrating pathogens via production of immunoregulatory mediators. Eosinophils can also be recruited by activated MCs in inflamed tissues. 270 However, the majority of studies focusing on the role of MCs in helminthic infections are conducted in rodents, thus more studies should aim to focus on human infections to better understand the specific contribution of MCs.
Helminthic infections are also characterized by high IgE production and marked blood and tissue eosinophilia. 272 Comparable to MCs, eosinophils can form aggregates around parasites and kill them by ADCC 273 or through the release of granule proteins and ROS production. 272 In contrast, there may be situations where eosinophils may instead benefit parasitosis and be detrimental to host cells and tissues, 274 since their granule proteins and other mediators have strong cytotoxic activity. 272 In addition to viral, fungal and parasitic infections, MCs and eo- 
| CONCLUSIONS
MCs and eosinophils are complex immune cells that develop and function similarly in many ways. They can be beneficial when protecting us from pathogens, but they can also be detrimental in when activated in- should allow us to best determine when targeting of these cells is warranted or best avoided to maintain optimal health.
